🚀 VC round data is live in beta, check it out!
Phibro Animal Health Valuation Multiples
Discover revenue and EBITDA valuation multiples for Phibro Animal Health and similar public comparables like D&D Pharmatech, BioKangtai, AstraZeneca Pharma India, Mabwell and more.
Phibro Animal Health Overview
About Phibro Animal Health
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.
Founded
2014
HQ
Employees
2.5K
Website
Sectors
Financials (LTM)
EV
$3B
Phibro Animal Health Financials
Phibro Animal Health reported last 12-month revenue of $1B and EBITDA of $238M.
In the same LTM period, Phibro Animal Health generated $496M in gross profit, $238M in EBITDA, and $89M in net income.
Revenue (LTM)
Phibro Animal Health P&L
In the most recent fiscal year, Phibro Animal Health reported revenue of $1B and EBITDA of $184M.
Phibro Animal Health expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $1B | XXX | $1B | XXX | XXX | XXX |
| Gross Profit | $496M | XXX | $400M | XXX | XXX | XXX |
| Gross Margin | 34% | XXX | 31% | XXX | XXX | XXX |
| EBITDA | $238M | XXX | $184M | XXX | XXX | XXX |
| EBITDA Margin | 16% | XXX | 14% | XXX | XXX | XXX |
| EBIT Margin | 14% | XXX | 11% | XXX | XXX | XXX |
| Net Profit | $89M | XXX | $48M | XXX | XXX | XXX |
| Net Margin | 6% | XXX | 4% | XXX | XXX | XXX |
| Net Debt | — | — | $651M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Phibro Animal Health Stock Performance
Phibro Animal Health has current market cap of $2B, and enterprise value of $3B.
Market Cap Evolution
Phibro Animal Health's stock price is $57.07.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $3B | $2B | 0.0% | XXX | XXX | XXX | $1.19 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialPhibro Animal Health Valuation Multiples
Phibro Animal Health trades at 2.1x EV/Revenue multiple, and 12.6x EV/EBITDA.
EV / Revenue (LTM)
Phibro Animal Health Financial Valuation Multiples
As of April 19, 2026, Phibro Animal Health has market cap of $2B and EV of $3B.
Equity research analysts estimate Phibro Animal Health's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Phibro Animal Health has a P/E ratio of 26.0x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $2B | XXX | $2B | XXX | XXX | XXX |
| EV (current) | $3B | XXX | $3B | XXX | XXX | XXX |
| EV/Revenue | 2.1x | XXX | 2.3x | XXX | XXX | XXX |
| EV/EBITDA | 12.6x | XXX | 16.4x | XXX | XXX | XXX |
| EV/EBIT | 15.2x | XXX | 20.6x | XXX | XXX | XXX |
| EV/Gross Profit | 6.1x | XXX | 7.5x | XXX | XXX | XXX |
| P/E | 26.0x | XXX | 47.9x | XXX | XXX | XXX |
| EV/FCF | 30.8x | XXX | 28.0x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Phibro Animal Health Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Phibro Animal Health Margins & Growth Rates
Phibro Animal Health's revenue in the last 12 month grew by 6%.
Phibro Animal Health's revenue per employee in the last FY averaged $0.5M, while opex per employee averaged $0.1M for the same period.
Phibro Animal Health's rule of 40 is 26% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Phibro Animal Health's rule of X is 40% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Phibro Animal Health Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 6% | XXX | 15% | XXX | XXX | XXX |
| EBITDA Margin | 16% | XXX | 14% | XXX | XXX | XXX |
| EBITDA Growth | 12% | XXX | 37% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 26% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 40% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.5M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 22% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Phibro Animal Health Public Comps
See public comps and valuation multiples for other Biopharmaceuticals comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Phibro Animal Health | XXX | XXX | XXX | XXX | XXX | XXX |
| D&D Pharmatech | XXX | XXX | XXX | XXX | XXX | XXX |
| BioKangtai | XXX | XXX | XXX | XXX | XXX | XXX |
| AstraZeneca Pharma India | XXX | XXX | XXX | XXX | XXX | XXX |
| Mabwell | XXX | XXX | XXX | XXX | XXX | XXX |
| Sarepta Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Phibro Animal Health M&A Activity
Phibro Animal Health acquired XXX companies to date.
Last acquisition by Phibro Animal Health was on XXXXXXXX, XXXXX. Phibro Animal Health acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Phibro Animal Health
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialPhibro Animal Health Investment Activity
Phibro Animal Health invested in XXX companies to date.
Phibro Animal Health made its latest investment on XXXXXXXX, XXXXX. Phibro Animal Health invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Phibro Animal Health
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Phibro Animal Health
| When was Phibro Animal Health founded? | Phibro Animal Health was founded in 2014. |
| Where is Phibro Animal Health headquartered? | Phibro Animal Health is headquartered in United States. |
| How many employees does Phibro Animal Health have? | As of today, Phibro Animal Health has over 2K employees. |
| Who is the CEO of Phibro Animal Health? | Phibro Animal Health's CEO is Jack Clifford Bendheim. |
| Is Phibro Animal Health publicly listed? | Yes, Phibro Animal Health is a public company listed on Nasdaq. |
| What is the stock symbol of Phibro Animal Health? | Phibro Animal Health trades under PAHC ticker. |
| When did Phibro Animal Health go public? | Phibro Animal Health went public in 2014. |
| Who are competitors of Phibro Animal Health? | Phibro Animal Health main competitors are D&D Pharmatech, BioKangtai, AstraZeneca Pharma India, Mabwell. |
| What is the current market cap of Phibro Animal Health? | Phibro Animal Health's current market cap is $2B. |
| What is the current revenue of Phibro Animal Health? | Phibro Animal Health's last 12 months revenue is $1B. |
| What is the current revenue growth of Phibro Animal Health? | Phibro Animal Health revenue growth (NTM/LTM) is 6%. |
| What is the current EV/Revenue multiple of Phibro Animal Health? | Current revenue multiple of Phibro Animal Health is 2.1x. |
| Is Phibro Animal Health profitable? | Yes, Phibro Animal Health is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Phibro Animal Health? | Phibro Animal Health's last 12 months EBITDA is $238M. |
| What is Phibro Animal Health's EBITDA margin? | Phibro Animal Health's last 12 months EBITDA margin is 16%. |
| What is the current EV/EBITDA multiple of Phibro Animal Health? | Current EBITDA multiple of Phibro Animal Health is 12.6x. |
| What is the current FCF of Phibro Animal Health? | Phibro Animal Health's last 12 months FCF is $98M. |
| What is Phibro Animal Health's FCF margin? | Phibro Animal Health's last 12 months FCF margin is 7%. |
| What is the current EV/FCF multiple of Phibro Animal Health? | Current FCF multiple of Phibro Animal Health is 30.8x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.